|
Match
|
Document |
Document Title |
|
|
7632520 |
Synergistic antibacterial formulation and to a method of making the same
A synergistic antibacterial formulation and a method of making the same is disclosed. The composition contains Cefixime Trihydrate+Cloxacillin Sodium+ Lactobacillus sporogenes spores. The...
|
|
|
7625745 |
Alcohol-tolerant malolactic strains for the maturation of wines with average or high pH
Lactic bacterial strains of the genera Lactobacillus and Pediococcus which are capable of initiating and carrying out a complete malolactic fermentation on direct introduction, in the dried,...
|
|
|
7550285 |
Endotoxin binding lactic acid bacteria and bifidobacteria
The invention relates to the use of at least one strain of lactic acid bacteria and/or bifidobacteria having hydrophobic surface properties, for the preparation of a composition intended for the...
|
|
|
7541173 |
Solvent tolerant microorganisms and methods of isolation
Lactobacillus bacteria having enhanced tolerance to butanols have been isolated. The bacteria are useful for the fermentive production of butanol. New methods for the isolation of butanol tolerant...
|
|
|
7537925 |
Mutated Lactococcus strain
A mutant of Lactococcus lactis spp. lactis , which produces lactate at high volumetric and specific productivity as well as high amounts of lactate dehydrogenase, as well as the use of said...
|
|
|
7517681 |
Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
New strains of Lactobacillus that have been selected for their capability of improved reduction the number of Streptococcus mutans in the mouth of mammals through inhibiting activity in...
|
|
|
7507572 |
Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains
The invention refers to a composition comprising one or more tannase-producing strains of Lactobacillus having the ability to adhere to the human intestinal mucosa in combination with tannin. New...
|
|
|
7501274 |
Lactic acid bacteria with immunoregulating activities
The invention provides novel lactic acid bacteria having immunoregulating activities and usable in food and drinks, medicaments, and other applications. Specifically, the invention provides novel...
|
|
|
7495092 |
Compositions comprising promoter sequences and methods of use
Nucleic acid molecules, fragments and variants thereof having promoter activity are provided in the current invention. The invention also provides vectors containing a nucleic acid molecule of the...
|
|
|
7491386 |
Treatment of actinomyces naeslundii-related diseases with exogenous lactic bacteria strains
A lactic bacteria strain that is exogenous to the oral microflora is selected for its ability to adhere the pellicle of the teeth and to produce a growth inhibition factor. This strain is used for...
|
|
|
7468270 |
Probiotic strains, a process for the selection of them, compositions thereof, and their use
The present invention relates to a novel process for the selection of new probiotic strains which comprises the following steps: a) selecting for non-pathogenic strains which are capable of...
|
|
|
7468182 |
Lactobacillus acidophilus nucleic acids and uses thereof
Lactobacillus acidophilus NCFM nucleic acid molecules, polypeptides, fragments and variants thereof are provided in the current invention. In addition, fusion proteins, antigenic peptides, and...
|
|
|
7465576 |
Method for treating periodontal disease with a bacteriocidal disinfectant
A method for treating periodontal disease by first disinfecting the affected part with a bactericidal disinfectant containing ferric ions (Fe +3 ) and L-ascorbic acid as the principal components...
|
|
|
7465575 |
Metabolically engineered lactic acid bacteria and their use
Mutants of lactic acid bacteria including Lactococcus lactis which are defective in pyruvate formate-lyase production and/or in their lactate dehydrogenase (Ldh) production and methods of...
|
|
|
7435574 |
NADH oxidase from Lactobacillus
The present invention is directed to a new NADH oxidase from Lactobacillus , nucleic acids encoding the NADH oxidase, methods of producing the NADH oxidase, as well as there use in producing...
|
|
|
7427398 |
Mammalian animal composition
The present invention relates to the use of probiotic microorganism in the manufacture of a composition for the prevention or reduction of gastrointestinal Campylobacter infection in a mammalian...
|
|
|
7390519 |
Probiotic Lactobacillus salivarius strains
A Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants thereof are useful in the prophylaxis and/or treatment of inflammatory activity especially...
|
|
|
7384628 |
Lactic acid bacteria and its use in direct-fed microbials
A composition comprising lactic acid bacteria that are selected from at least one of Lactococcus lactis, Lactobacillus lactis , and Lactobacillus brevis . The composition is suitable for...
|
|
|
7381406 |
Probiotic lactobacillus strains for pets
The present invention provides novel strains of probiotics for use in the gastrointestinal tract of a pet. The probiotics of the present invention are capable of fermenting starch to produce lactic...
|
|
|
7374924 |
Use of selected lactic acid bacteria for reducing infantile colic
The invention herein provides certain strains of lactic acid bacteria selected for their capability of promoting production of IL-10 and consequently proliferation of CD4+CD25+ TR cells, for...
|
|
|
7358083 |
Food-grade cloning vector and their use in lactic acid bacteria
Novel food-grade cloning vectors comprising a nonsense mutation suppressor-encoding gene, which vector, when it is present in a lactic acid bacterial strain, permits such a strain to have an...
|
|
|
7354757 |
Lactobacillus brevis strain
Lactobacillus strains that have a genetic Profile I based on Apa I, Not I, and Xba I digests are provided. Preferably, the strains decrease level of at least one of coliforms and E. coli within...
|
|
|
7351572 |
Microorganism strain GM-090 of Lactobacillus fermentum and its use for stimulating IFN-γ secretion and/or treating allergy
The present invention provides an isolated microorganism strain, Lactobacillus fermentum GM-090, which is found to be effective in stimulating IFN-γ secretion and/or treating allergy. The use of...
|
|
|
7329741 |
Polynucleotides that hybridize to DP-75 and their use
The present invention is a novel nucleic acid sequence which hybridizes to SEQ ID NO:6 or fragments thereof under stringent conditions, or fragments thereof. The invention also includes diagnostic...
|
|
|
7326558 |
Process for treating spirulina
The treatment of spirulina by a process which includes placing spirulina that has not been previously heat-sterilized, lactic acid bacteria and sugar in water, then culturing the lactic acid...
|
|
|
RE40023 |
Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
A pharmaceutical composition containing several different bacteria including Streptococcus thermophilus, Lactobacilli and Bifidobacteria is disclosed. The bacteria are present in the composition at...
|
|
|
7312067 |
Lactic acid producing bacteria for use as probiotic organisms in the human vagina
The present invention discloses novel isolated strains of lactic acid producing bacteria of the genera Lactobacillus and Pediococcus , and a method for isolation of such bacterial strains,...
|
|
|
7300787 |
Lactobacillus strains and use thereof in fermentation for L-lactic acid production
The present invention relates to L-lactic acid producing bacterial strains, including Lactobacilli such as NRRL B-30568 (ADM B64), NRRL B-30569 (ADM DEC2-2B), NRRL B-30570 (ADM RP1A-4E), NRRL...
|
|
|
7282354 |
Method for producing fermented milk product
There is provided a fermented milk product that contains lactic acid bacteria capable of producing a large amount of lactotripeptide and a large amount of active ingredient having hypotensive...
|
|
|
7270994 |
Lactobacillus casei Bd-II stain and used to reduce blood cholesterol
The invention disclosed a kind of lactobacillus casei Bd-II, the accession number of the deposit of which is CGMCC NO.0849, and also disclosed a use of it for reducing blood lipid level. Further,...
|
|
|
7244424 |
Strain of micro-organism Lactobacillus fermentum ME-3 as novel anti-microbiol and anti-oxidative probiotic
The strain of micro-organism Lactobacillus fermentum ME-3 is a novel anti-microbial and anti-oxidative probiotic. It has a high anti-microbial effect on Escherichia coli, Shigella sonnei,...
|
|
|
7241441 |
Microorganism Pediococcus pentosaceus EROM101, having immune enhancement, anticancer and antimicrobial activities
The present invention relates to a novel Pediococcus genus microorganism and more particularly, Pediococcus pentosaceus EROM101 (KCCM-10517) originated from human intestines having immune...
|
|
|
7238351 |
Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it
The method of producing a microbial adherence inhibitor for administration to food animals to control the incidents of acidosis in food animals by preventing the adherence of colony-forming lactic...
|
|
|
7235395 |
Lactic acid bacteria as agents for treating and preventing allergy
The present invention pertains to novel strains of lactic acid bacteria capable of reducing an individual's tendency to react allergic against a variety of different allergens. In particular, the...
|
|
|
7229818 |
Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life
Disclosed is a formulation for preserving the life of probiotic bacteria during passage through the stomach, while permitting their release in the intestine, and which has a low water activity and...
|
|
|
7202219 |
Use of D-tagatose as a prebiotic food component
Oral intake of D-tagatose in a prebiotic food induces production of butyrate and stimulates the growth of beneficial bacteria in the human colon. Therefore it is believed to be useful in food or...
|
|
|
7195906 |
Bifidobacterium in the treatment of inflammatory disease
A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the...
|
|
|
7192581 |
Lactobacillus reuteri useful as probiotics
The present invention relates to a Lactobacillus reuteri variant from animal sources that inhibits rotavirus infection and other pathogenic microorganisms, as well as being tolerant of gastric...
|
|
|
7189390 |
Probiotics for pet food applications
The present invention relates to novel lactic acid bacterial micro-organisms that have been isolated and selected for their probiotic potential and their use for the preparation of petfood...
|
|
|
7186545 |
Probiotic strains from Lactobacillus salivarius and antimicrobial agents obtained therefrom
A strain of Lactobacillus salivarius isolated from resected and washed human gastrointestinal tract inhibits a broad range of Gram positive and Gram negative microorganisms and secretes a product...
|
|
|
7183101 |
NCC2705—the genome of a bifidobacterium
A novel microorganism of the genus Bifidobacterium longum , in particular to its genomic and plasmid sequence and to a method of producing polypeptides of said Bifidobacterium , respectively....
|
|
|
7183108 |
Selection and uses of lactic acid bacteria strains modulating non-specific immunity
The invention concerns lactic acid bacteria strains capable of regulating the production of NO and inflammatory cytokines by enterocytes, depending on the inflammatory condition of said...
|
|
|
7172777 |
Powder for preparation of a probiotic yogurt food
The invention relates to a powder for preparation of a probiotic yogurt food. The powder contains probiotic cultures with a prespecified proportion of living probiotic lactic-acid bacteria and a...
|
|
|
7169911 |
AbiZ phage resistance gene
A first aspect of the present invention is an isolated nucleic acid encoding a phage abortive defense protein, the isolated nucleic acid selected from the group consisting of: (a) isolated nucleic...
|
|
|
7150986 |
Lactic acid bacteria-containing probiotics products
The present invention provides a probiotics product comprising, as an effective component, lactic acid bacteria belonging to Lactobacillus salivarius possessing high adhesiveness to mucous...
|
|
|
7147847 |
Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria
Disclosed is the use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction, and pharmaceutical or dietetic compositions containing such bacteria....
|
|
|
7138113 |
Glycoprotein matrix compositions and methods related thereto
A composition is provided that includes a biologically active compound bound by a glycoprotein matrix. A method is also provided for the manufacture of a composition of the invention. The...
|
|
|
7125708 |
Composition comprising a Lactobacillus pentosus strain and uses thereof
A novel probiotic strain termed Lactobacillus pentosus NCIMB 41114 is capable of preventing growth of pathogenic microorganisms in the GI tract. In particular, this bacterium inhibits Candida ...
|
|
|
7122370 |
Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life
Disclosed is a formulation for preserving the life of probiotic bacteria during passage through the stomach, while permitting their release in the intestine, and which has a low water activity and...
|
|
|
7112322 |
Probiotics in primary prevention of atopic diseases
The present invention is in the field of prophylaxis of allergies, and relates specifically to primary prevention of atopic diseases by administering probiotic bacteria, beneficial microbes of the...
|